trial · primary record
Risk-Adapted Segmental Esophagus-Sparing IMRT/VMAT
Non-Small Cell Lung Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 140 |
| Primary completion | 2031-12-30 |
| Primary endpoint | Incidence of Grade 2 or Higher Acute Radiation Esophagitis (CTCAE v5.0) |
| Registry ID | NCT07908732 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:05.468Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07908732
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.